MR imaging of primary intracranial malignant lymphoma

Radiat Med. 1995 Mar-Apr;13(2):51-7.

Abstract

Magnetic resonance imaging (MRI) was performed in ten patients with intracranial lymphoma. Seven were pathologically confirmed and three were clinically diagnosed. Nineteen lesions were found among the ten cases. None had acquired immunodeficiency syndrome (AIDS) or had received immunosuppression therapy. Two lesions were in the lateral and third ventricles, and the others were predominantly in the corpus callosum, deep white matter, or central gray matter. Four patients had multiple lesions. All had mild to severe edema. On T1-weighted images, all lesions showed hypointensity. On T2-weighted images, three lesions showed definite hypointensity to gray matter, and the others showed hyperintensity. The contour of all lesions was well demarcated from the surrounding edema. Eight cases were scanned before and after intravenous administration of 0.1 mmol/kg of gadolinium-dimethylene triaminepentaacetic acid (Gd-DTPA), and all exhibited homogeneous enhancement. Three cases showed blurred enhancement margins. Four cases showed hemorrhage, and the frequency of hemorrhage was higher than in previous reports. Pathological examination was performed in seven cases. All showed dense concentric lymphoma cells without necrosis. There was no pathological difference between the hyperintense and hypointense lesions on T2-weighted images.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Brain Neoplasms / diagnosis*
  • Cerebral Ventricle Neoplasms / diagnosis
  • Contrast Media
  • Corpus Callosum
  • Female
  • Gadolinium
  • Gadolinium DTPA
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / diagnosis*
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Organometallic Compounds
  • Pentetic Acid / analogs & derivatives
  • Predictive Value of Tests

Substances

  • Contrast Media
  • Organometallic Compounds
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA